Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Behavioral and Physiological Effects of THC and CBD
NCT03832816Phase 1Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Dec 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dronabinol and cannabidiol (8 arms), sponsored by Johns Hopkins University. Primary endpoints: Change in blood cortisol at 4 hours, Change in blood Adrenocorticotropic hormone at 4 hours and 6 more. Planned start Dec 2019; status: withdrawn.
02
Drugs
dronabinolcannabidiol
Beyond the preview
Go deeper on NCT03832816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03832816.